首页> 美国卫生研究院文献>Frontiers in Neuroscience >Both exogenous 5-HT and endogenous 5-HT released by fluoxetine enhance distension evoked propulsion in guinea-pig ileum in vitro
【2h】

Both exogenous 5-HT and endogenous 5-HT released by fluoxetine enhance distension evoked propulsion in guinea-pig ileum in vitro

机译:氟西汀释放的外源性5-HT和内源性5-HT均可增强豚鼠回肠在体外引起的扩张诱发的推进作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The roles of 5-HT3 and 5-HT4 receptors in the modulation of intestinal propulsion by luminal application of 5-HT and augmentation of endogenous 5-HT effects were studied in segments of guinea-pig ileum in vitro. Persistent propulsive contractions evoked by saline distension were examined using a modified Trendelenburg method. When 5-HT (30 nM), fluoxetine (selective serotonin reuptake inhibitor; 1 nM), 2-methyl-5-HT (5-HT3 receptor agonist; 1 mM), or RS 67506 (5-HT4 receptor agonist, 1 μM) was infused into the lumen, the pressure needed to initiate persistent propulsive activity fell significantly. A specific 5-HT4 receptor antagonist, SB 207266 (10 nM in lumen), abolished the effects of 5-HT, fluoxetine, and RS 67506, but not those of 2-methyl-5-HT. Granisetron (5-HT3 receptor antagonist; 1 μM in lumen) abolished the effect of 5-HT, fluoxetine, RS 67506, and 2-methyl-5-HT. The NK3 receptor antagonist SR 142801 (100 nM in lumen) blocked the effects of 5-HT, fluoxetine, and 2-methyl-5-HT. SB 207266, granisetron, and SR 142801 had no effect by themselves. Higher concentrations of fluoxetine (100 and 300 nM) and RS 67506 (3 and 10 μM) had no effect on the distension threshold for propulsive contractions. These results indicate that luminal application of exogenous 5-HT, or increased release of endogenous mucosal 5-HT above basal levels, acts to lower the threshold for propulsive contractions in the guinea-pig ileum via activation of 5-HT3 and 5-HT4 receptors and the release of tachykinins. The results further indicate that basal release of 5-HT is insufficient to alter the threshold for propulsive motor activity.
机译:在体外试验中,研究了5-HT3和5-HT4受体在腔内应用5-HT调节肠道推进和增强内源性5-HT效应中的作用。使用改良的特伦德伦伯卧位法检查了生理盐水膨胀引起的持续性推进性收缩。当5-HT(30 nM),氟西汀(选择性5-羟色胺再摄取抑制剂; 1 nM),2-甲基-5-HT(5-HT3受体激动剂; 1 mM)或RS 67506(5-HT4受体激动剂,1μM)时)注入腔内,开始持续推进活动所需的压力显着下降。特异的5-HT4受体拮抗剂SB 207266(管腔10 nM)消除了5-HT,氟西汀和RS 67506的作用,但没有消除2-甲基-5-HT的作用。 Granisetron(5-HT3受体拮抗剂;管腔内1μM)取消了5-HT,氟西汀,RS 67506和2-甲基-5-HT的作用。 NK3受体拮抗剂SR 142801(内腔100 nM)阻断了5-HT,氟西汀和2-甲基-5-HT的作用。 SB 207266,granisetron和SR 142801本身没有作用。较高浓度的氟西汀(100和300 nM)和RS 67506(3和10μM)对推进性收缩的扩张阈值没有影响。这些结果表明,外源性5-HT的腔内应用或内源性粘膜5-HT的释放高于基础水平,可通过激活5-HT3和5-HT4受体来降低豚鼠回肠中推进性收缩的阈值。和速激肽的释放。结果进一步表明5-HT的基础释放不足以改变推进运动活动的阈值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号